Brain Cancer

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, discusses the need for brain tumor awareness.

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, discusses what she is most looking forward to in the future of brain tumor research.

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, explains how clinicians may treat patients with gliomas of different grades.

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, discusses monitoring patients following their initial treatment.

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, discusses recent advancements in the treatment of brain tumors.

Approximately one in three patients diagnosed with cancer in Ontario presented to an ED in the 90 days preceding their diagnosis, according to findings published in Canadian Medical Association Journal.

In this video, Tracy T. Batchelor, MD, head of the department of neurology at Brigham and Women's Hospital, discusses the targeted therapies available or in development that target specific mutations in gliomas.

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets the immune checkpoint B7-H3 for diffuse intrinsic pontine glioma, or DIPG, a rare incurable pediatric brain tumor.

Higher omega-3 and omega-6 fatty acid levels may help reduce cancer risk, according to study findings.

People with MS had an increased risk for bladder, brain and cervical cancers compared with people without MS, according to a new study in Neurology, the medical journal of the American Academy of Neurology.